Literature DB >> 15847799

An efficient method for cloning human autoantigen-specific T cells.

Stuart I Mannering1, James A Dromey, Jessica S Morris, Daniel J Thearle, Kent P Jensen, Leonard C Harrison.   

Abstract

T-cell clones are valuable tools for investigating T-cell specificity in infectious, autoimmune and malignant diseases. T cells specific for clinically-relevant autoantigens are difficult to clone using traditional methods. Here we describe an efficient method for cloning human autoantigen-specific CD4+ T cells pre-labelled with CFSE. Proliferating, antigen-responsive CD4+ cells were identified flow cytometrically by their reduction in CFSE staining and single cells were sorted into separate wells. The conditions (cytokines, mitogens and tissue culture plates) for raising T-cell clones were optimised. Media supplemented with IL-2+IL-4 supported growth of the largest number of antigen-specific clones. Three mitogens, PHA, anti-CD3 and anti-CD3+anti-CD28, each stimulated the growth of similar numbers of antigen-specific clones. Cloning efficiency was similar in flat- and round-bottom plates. Based on these findings, IL-2+IL-4, anti-CD3 and round-bottom plates were used to clone FACS-sorted autoantigen-specific CFSE-labelled CD4+ T cells. Sixty proinsulin- and 47 glutamic acid decarboxylase-specific clones were obtained from six and two donors, respectively. In conclusion, the CFSE-based method is ideal for cloning rare, autoantigen-specific, human CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15847799     DOI: 10.1016/j.jim.2005.01.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

Review 1.  Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Authors:  S I Mannering; F S Wong; I Durinovic-Belló; B Brooks-Worrell; T I Tree; C M Cilio; N C Schloot; R Mallone
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

Review 2.  The case for an autoimmune aetiology of type 1 diabetes.

Authors:  S I Mannering; V Pathiraja; T W H Kay
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

3.  Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.

Authors:  Thomas Delong; Timothy A Wiles; Rocky L Baker; Brenda Bradley; Gene Barbour; Richard Reisdorph; Michael Armstrong; Roger L Powell; Nichole Reisdorph; Nitesh Kumar; Colleen M Elso; Megan DeNicola; Rita Bottino; Alvin C Powers; David M Harlan; Sally C Kent; Stuart I Mannering; Kathryn Haskins
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

Review 4.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

5.  Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.

Authors:  Michelle So; Colleen M Elso; Eleonora Tresoldi; Miha Pakusch; Vimukthi Pathiraja; John M Wentworth; Leonard C Harrison; Balasubramanian Krishnamurthy; Helen E Thomas; Christine Rodda; Fergus J Cameron; Jacinta McMahon; Thomas W H Kay; Stuart I Mannering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

6.  The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes.

Authors:  S I Mannering; S H Pang; N A Williamson; G Naselli; E C Reynolds; N M O'Brien-Simpson; A W Purcell; L C Harrison
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

7.  A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.

Authors:  Seung-Tae Lee; Shujuan Liu; Laszlo Radvanyi; Pariya Sukhumalchandra; Jeffrey J Molldrem; Eric D Wieder; Patrick Hwu; Yong-Jun Liu; Larry W Kwak; Gregory Lizée; Sattva S Neelapu
Journal:  J Immunol Methods       Date:  2007-10-09       Impact factor: 2.303

8.  Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.

Authors:  Tihamer Orban; Klara Farkas; Heyam Jalahej; Janos Kis; Andras Treszl; Ben Falk; Helena Reijonen; Joseph Wolfsdorf; Alyne Ricker; Jeffrey B Matthews; Nadio Tchao; Peter Sayre; Pete Bianchine
Journal:  J Autoimmun       Date:  2010-06       Impact factor: 7.094

9.  Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft: possible relevance to superior graft survival of HLA class II closely matched renal allografts.

Authors:  Qingyong Xu; Junglim Lee; Melissa Keller; William J Burlingham
Journal:  Transpl Immunol       Date:  2009-01-21       Impact factor: 1.708

10.  The insulin A-chain epitope recognized by human T cells is posttranslationally modified.

Authors:  Stuart I Mannering; Leonard C Harrison; Nicholas A Williamson; Jessica S Morris; Daniel J Thearle; Kent P Jensen; Thomas W H Kay; Jamie Rossjohn; Ben A Falk; Gerald T Nepom; Anthony W Purcell
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.